- Home
- INSM vs TKO Comparison
INSM vs TKO Comparison
Compare INSM & TKO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INSM
- TKO
- Stock Information
- Founded
- INSM 1988
- TKO 1980
- Country
- INSM United States
- TKO United States
- Employees
- INSM N/A
- TKO N/A
- Industry
- INSM Biotechnology: Pharmaceutical Preparations
- TKO
- Sector
- INSM Health Care
- TKO
- Exchange
- INSM Nasdaq
- TKO Nasdaq
- Market Cap
- INSM 12.5B
- TKO 10.1B
- IPO Year
- INSM 2000
- TKO N/A
- Fundamental
- Price
- INSM $72.27
- TKO $127.05
- Analyst Decision
- INSM Strong Buy
- TKO Strong Buy
- Analyst Count
- INSM 16
- TKO 15
- Target Price
- INSM $82.00
- TKO $129.80
- AVG Volume (30 Days)
- INSM 1.8M
- TKO 927.6K
- Earning Date
- INSM 10-24-2024
- TKO 11-27-2024
- Dividend Yield
- INSM N/A
- TKO N/A
- EPS Growth
- INSM N/A
- TKO N/A
- EPS
- INSM N/A
- TKO N/A
- Revenue
- INSM $328,605,000.00
- TKO $2,543,925,000.00
- Revenue This Year
- INSM $19.10
- TKO $66.09
- Revenue Next Year
- INSM $44.67
- TKO $11.25
- P/E Ratio
- INSM N/A
- TKO N/A
- Revenue Growth
- INSM 21.94
- TKO 107.77
- 52 Week Low
- INSM $21.92
- TKO $72.33
- 52 Week High
- INSM $80.53
- TKO $128.31
- Technical
- Relative Strength Index (RSI)
- INSM 46.30
- TKO 69.66
- Support Level
- INSM $71.11
- TKO $121.32
- Resistance Level
- INSM $73.81
- TKO $125.41
- Average True Range (ATR)
- INSM 2.15
- TKO 2.49
- MACD
- INSM -0.10
- TKO 0.43
- Stochastic Oscillator
- INSM 36.26
- TKO 99.81
About INSM Insmed Incorporated
Insmed Inc is a global biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the US for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. The company's earlier-stage clinical pipeline includes Brensocatib, a novel oral reversible inhibitor of dipeptidyl peptidase 1 with therapeutic potential in non-cystic fibrosis bronchiectasis and other inflammatory diseases; and INS1009, an inhaled formulation of a treprostinil prodrug that may offer a differentiated product profile for pulmonary arterial hypertension.
About TKO TKO Group Holdings Inc.
TKO Group Holdings Inc is a premium sports and entertainment company that comprises UFC, the world's mixed martial arts organization, and WWE, an integrated media organization and the recognized leader in sports entertainment.